Late complete heart block in an adult patient undergoing percutaneous ventricular septal defect closure

Journal of Invasive Cardiology

Volumn 20, Issue 6, 2008, Pages

  Collins, Nicholas J ^a   Benson, Lee ^b   Horlick, Eric ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BOSENTAN; CEFAZOLIN; ENDOTHELIN RECEPTOR ANTAGONIST; HEPARIN;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLEEDING; BRAIN VENTRICLE DILATATION; CASE REPORT; CLINICAL FEATURE; COMPLETE HEART BLOCK; ELECTROCARDIOGRAPHY; FEMALE; GENERAL ANESTHESIA; HEART ANEURYSM; HEART ASSIST DEVICE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESYNCOPE; PROPHYLAXIS; PULMONARY HYPERTENSION; SINUS BRADYCARDIA; TREATMENT OUTCOME; VEIN CATHETERIZATION;

ADULT; BALLOON OCCLUSION; CARDIOVASCULAR AGENTS; FEMALE; HEART BLOCK; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; RISK FACTORS; SULFONAMIDES; TIME FACTORS;

EID: 46349102230     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006;68:620-628.
2. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defects: Results of the European Registry. Eur Heart J 2007;28:2361-2368.
3. Butera G, Massimo C, Mario C. Late complete atriovenous block after percutaneous closure of a perimembranous ventricular septal defect. Catheter Cardiovasc Interv 2006;67:938-941.
4. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol 2005;96:52L-58L.
5. Pinto RJ, Dalvi BV, Sharma S. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: Preliminary experience with 18-month follow up. Catheter Cardiovasc Interv 2006;68:145-152.
6. Walsh MA, Coleman DM, Oslizlok P, Walsh KP. Percutaneous closure of postoperative ventricular septal defects with the Amplatzer device. Catheter Cardiovasc Interv 2006;67:445-451; Discussion 452.
7. Yip WC, Zimmerman F, Hijazi ZM. Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect. Catheter Cardiovasc Interv 2005;66:436-441.
8. Michel-Behnke I, Le TP, Waldecker B, et al. Percutaneous closure of congenital and acquired ventricular septal defects - Considerations on selection of the occlusion device. J Interv Cardiol 2005;18:89-99.
9. Arora R, Trehan V, Kumar A, et al. Transcatheter closure of congenital ventricular septal defects: experience with various devices. J Interv Cardiol 2003;16:83-91.
10. Pedra CA, Pedra SR, Esteves CA, et al. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc Interv 2004;61:403-410.
11. Suda K, Raboisson MJ, Piette E, et al. Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device. J Am Coll Cardiol 2004;43:1677-1682.
12. Silversides CK, Siu SC, McLaughlin PR, et al. Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart 2004;90:1194-1198.
13. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, Van Domburg R, Van Rijen EH, Utens EM, Bogers AJ, Simoons ML. Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years. Eur Heart J 2004;25:1057-1062.